Company profile KZIA
After 39 days of this quarter the interest is at 63.0. Based on that we can calculate that during remaining 52 days it will total up to 147.0. Kazia Therapeutics expected interest is significantly higher compared to same quarter last year (+104.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 115 248.5% QoQ | 109 -5.2% QoQ | 135 23.9% QoQ |
| 2020 | 111 236.4% YoY -17.8% QoQ | 112 -2.6% YoY 0.9% QoQ | 191 75.2% YoY 70.5% QoQ | 258 91.1% YoY 35.1% QoQ |
| 2021 | 211 90.1% YoY -18.2% QoQ | 133 18.8% YoY -37.0% QoQ | 120 -37.2% YoY -9.8% QoQ | 181 -29.8% YoY 50.8% QoQ |
| 2022 | 67 -68.2% YoY -63.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 130 8.3% YoY inf% QoQ | 130 -28.2% YoY 0.0% QoQ |
| 2023 | 72 7.5% YoY -44.6% QoQ | 112 inf% YoY 55.6% QoQ | 35 -73.1% YoY -68.8% QoQ | 106 -18.5% YoY 202.9% QoQ |
| 2024 | 63 -12.5% YoY -40.6% QoQ | - | - | - |
There is not enough data for Kazia Therapeutics to provide correlation calculation
The average 5 years interest of Kazia Therapeutics was 9.29 per week. The last year interest of Kazia Therapeutics compared to the last 5 years has changed by -19.7%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -6.28%.
There is not enough data for Kazia Therapeutics Limited to provide analysis
There is not enough data for Kazia Therapeutics Limited to provide correlation calculation
There is not enough data for Kazia Therapeutics Limited to provide analysis
After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0. Kazia Therapeutics stock expected interest is significantly lower compared to previous quarter (-67.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 124 | 0 -100.0% QoQ | 104 inf% QoQ | 0 -100.0% QoQ |
| 2020 | 25 -79.8% YoY inf% QoQ | 191 inf% YoY 664.0% QoQ | 107 2.9% YoY -44.0% QoQ | 195 inf% YoY 82.2% QoQ |
| 2021 | 94 276.0% YoY -51.8% QoQ | 185 -3.1% YoY 96.8% QoQ | 38 -64.5% YoY -79.5% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 139 47.9% YoY inf% QoQ | 0 -100.0% YoY -100.0% QoQ | 69 81.6% YoY inf% QoQ | 29 inf% YoY -58.0% QoQ |
| 2023 | 89 -36.0% YoY 206.9% QoQ | 135 inf% YoY 51.7% QoQ | 182 163.8% YoY 34.8% QoQ | 188 548.3% YoY 3.3% QoQ |
| 2024 | 26 -70.8% YoY -86.2% QoQ | - | - | - |
There is not enough data for Kazia Therapeutics stock to provide correlation calculation
The average 5 years interest of Kazia Therapeutics stock was 7.36 per week. The last year interest of Kazia Therapeutics stock compared to the last 5 years has changed by 55.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 134.91%.
After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 69 | 0 -100.0% QoQ | 101 inf% QoQ | 331 227.7% QoQ |
| 2020 | 138 100.0% YoY -58.3% QoQ | 169 inf% YoY 22.5% QoQ | 130 28.7% YoY -23.1% QoQ | 194 -41.4% YoY 49.2% QoQ |
| 2021 | 206 49.3% YoY 6.2% QoQ | 47 -72.2% YoY -77.2% QoQ | 68 -47.7% YoY 44.7% QoQ | 69 -64.4% YoY 1.5% QoQ |
| 2022 | 119 -42.2% YoY 72.5% QoQ | 151 221.3% YoY 26.9% QoQ | 94 38.2% YoY -37.7% QoQ | 78 13.0% YoY -17.0% QoQ |
| 2023 | 52 -56.3% YoY -33.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 27 -71.3% YoY inf% QoQ | 74 -5.1% YoY 174.1% QoQ |
| 2024 | 31 -40.4% YoY -58.1% QoQ | - | - | - |
There is not enough data for Kazia Therapeutics news to provide correlation calculation
The average 5 years interest of Kazia Therapeutics news was 8.23 per week. The last year interest of Kazia Therapeutics news compared to the last 5 years has changed by -69.14%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -77.26%.
There is not enough data for Paxalisib drug to provide analysis
There is not enough data for Paxalisib drug to provide correlation calculation
There is not enough data for Paxalisib drug to provide analysis
There is not enough data for EVT801 drug to provide analysis
There is not enough data for EVT801 drug to provide correlation calculation
There is not enough data for EVT801 drug to provide analysis
There is not enough data for Kazia Therapeutics CEO to provide analysis
There is not enough data for Kazia Therapeutics CEO to provide correlation calculation
There is not enough data for Kazia Therapeutics CEO to provide analysis
There is not enough data for Kazia Therapeutics CFO to provide analysis
There is not enough data for Kazia Therapeutics CFO to provide correlation calculation
There is not enough data for Kazia Therapeutics CFO to provide analysis
There is not enough data for Kazia Therapeutics headquarters to provide analysis
There is not enough data for Kazia Therapeutics headquarters to provide correlation calculation
There is not enough data for Kazia Therapeutics headquarters to provide analysis